Stocklytics Platform
Johnson & Johnson
JNJ54
$159.39arrow_drop_down0.39%-$0.62
NYSE - As of Apr 10, 5:20 PM EDT Market Closed
S&P500
JNJ54

$159.39

arrow_drop_down0.39%

Performance History

no data available for performance history chart

There's no data available for performance history chart

no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$788.17
Perf. (24h)arrow_drop_down0.11%-$0.91
Market Cap$708.73B
Price$538.05
Perf. (24h)arrow_drop_down0.45%-$2.44
Market Cap$494.34B
Price$199.86
Perf. (24h)arrow_drop_down0.88%-$1.77
Market Cap$356.69B
Price$131.07
Perf. (24h)arrow_drop_down0.49%-$0.65
Market Cap$228.28B

About Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) is a multinational corporation that specializes in healthcare, consumer goods, and pharmaceutical products. Founded in 1886, the company has grown to become one of the largest and most well-known healthcare companies in the world. With a global presence in over 60 countries, Johnson & Johnson is committed to improving health and well-being for individuals of all ages.
The stock price history of Johnson & Johnson has been quite impressive. Over the years, the company has consistently delivered strong financial performance, which has translated into solid returns for its shareholders. Despite occasional fluctuations in the market, JNJ stock has shown resilience and has been able to weather economic downturns. This has made it a favorite among long-term investors who are seeking stability and consistent growth.
Sector
Healthcare
Industry
Drug Manufacturers—General
CEO
Mr. Joaquin Duato
Headquarters
New Brunswick
Employees
152700
Exchange
NYSE
add Johnson & Johnson to watchlist

Keep an eye on Johnson & Johnson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Johnson & Johnson's (JNJ) price per share?

The current price per share for Johnson & Johnson (JNJ) is $159.39. The stock has seen a price change of -$0.63 recently, indicating a -0.39% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Johnson & Johnson (JNJ)?

For Johnson & Johnson (JNJ), the 52-week high is $169.85, which is 6.56% from the current price. The 52-week low is $141.13, the current price is 12.94% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Johnson & Johnson (JNJ) a growth stock?

Johnson & Johnson (JNJ) has shown an average price growth of -1.65% over the past three years. It has received a score of 46 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Johnson & Johnson as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Johnson & Johnson (JNJ) stock price performance year to date (YTD)?

As of the latest data, Johnson & Johnson (JNJ) has a year-to-date price change of 10.21%. Over the past month, the stock has experienced a price change of -4.72%. Over the last three months, the change has been 10.54%. Over the past six months, the figure is -0.69%. Looking at a longer horizon, the five-year price change stands at 18.8%.
help

Is Johnson & Johnson (JNJ) a profitable company?

Johnson & Johnson (JNJ) has a net income of $14.07B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.07% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $88.82B, with a revenue growth rate of 4.3%, providing insight into the company's sales performance and growth. The gross profit is $61.35B. Operating income is noted at $22.15B. Furthermore, the EBITDA is $31.83B.
help

What is the market capitalization of Johnson & Johnson (JNJ)?

Johnson & Johnson (JNJ) has a market capitalization of $397.31B. The average daily trading volume is 159.32, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level